WhatsApp

A Gentler Chemotherapy Option for Cervical Cancer Treatment

You are here >> Home > Latest Updates > Cervical Cancer > A Gentler…

Comparison of nedaplatin and cisplatin in concurrent chemoradiotherapy for cervical cancer a systematic review and meta-analysis.DOI 10.1007s10147-026-02968-6

For women with locally advanced cervical cancer, the usual treatment is radiation therapy combined with a chemotherapy drug called cisplatin.

This approach helps radiation work better against cancer. But cisplatin can cause strong side effects, especially kidney damage, nausea, and vomiting, which sometimes makes treatment difficult to complete.


Researchers recently compared cisplatin with a similar drug called nedaplatin, which may be easier on the body. They reviewed 17 clinical trials that studied both treatments in women receiving radiation therapy for cervical cancer.


The results showed that both drugs were equally effective at controlling cancer and survival after three years. However, nedaplatin caused far fewer kidney-related side effects. It also led to less severe nausea, vomiting, and anemia.
In the short term, patients receiving nedaplatin even showed slightly better outcomes, including lower death rates after one year and fewer cases of disease progression.
Because of its lower toxicity, nedaplatin may be a good option for patients who cannot tolerate cisplatin, especially those who are older, frail, or have kidney problems.

Researchers say larger studies with longer follow-up are still needed, but this evidence suggests that nedaplatin could become an important alternative chemotherapy option for cervical cancer treatment.

Rate this post
dr swati shah - uro & gynec cancer surgeon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.